ACETAMINOPHEN\CHLORPHENIRAMINE\SODIUM ASCORBATE: 13 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
13
Total FAERS Reports
0
Deaths Reported
6
Hospitalizations
13
As Primary/Secondary Suspect
8
Life-Threatening
Active Ingredient: ACETAMINOPHEN\CHLORPHENIRAMINE MALEATE\SODIUM ASCORBATE ·
First Report: 20180403 · Latest Report: 20180403
What Are the Most Common ACETAMINOPHEN\CHLORPHENIRAMINE\SODIUM ASCORBATE Side Effects?
#1 Most Reported
Drug abuse
8 reports (61.5%)
#2 Most Reported
Psychomotor hyperactivity
7 reports (53.8%)
#3 Most Reported
Coma
7 reports (53.8%)
All ACETAMINOPHEN\CHLORPHENIRAMINE\SODIUM ASCORBATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug abuse | 8 | 61.5% | 0 | 1 |
| Coma | 7 | 53.9% | 0 | 0 |
| Psychomotor hyperactivity | 7 | 53.9% | 0 | 0 |
| Abdominal pain | 6 | 46.2% | 0 | 6 |
| Acute kidney injury | 6 | 46.2% | 0 | 6 |
| Electrocardiogram t wave peaked | 6 | 46.2% | 0 | 6 |
| Heart rate increased | 6 | 46.2% | 0 | 6 |
| Hyperkalaemia | 6 | 46.2% | 0 | 6 |
| Hyperleukocytosis | 6 | 46.2% | 0 | 6 |
| Hypotension | 6 | 46.2% | 0 | 6 |
| Intentional overdose | 6 | 46.2% | 0 | 6 |
| Livedo reticularis | 6 | 46.2% | 0 | 6 |
| Prothrombin time abnormal | 6 | 46.2% | 0 | 6 |
| Toxicity to various agents | 6 | 46.2% | 0 | 6 |
| Vomiting | 6 | 46.2% | 0 | 6 |
Who Reports ACETAMINOPHEN\CHLORPHENIRAMINE\SODIUM ASCORBATE Side Effects? Age & Gender Data
Gender: 0.0% female, 100.0% male. Average age: 17.8 years. Most reports from: FR. View detailed demographics →
Is ACETAMINOPHEN\CHLORPHENIRAMINE\SODIUM ASCORBATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 7 | 0 | 0 |
What Is ACETAMINOPHEN\CHLORPHENIRAMINE\SODIUM ASCORBATE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 11 |
Official FDA Label for ACETAMINOPHEN\CHLORPHENIRAMINE\SODIUM ASCORBATE
Official prescribing information from the FDA-approved drug label.